<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32306066</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>02</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0533</ISSN><JournalIssue CitedMedium="Internet"><Volume>140</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Acta neuropathologica</Title><ISOAbbreviation>Acta Neuropathol</ISOAbbreviation></Journal><ArticleTitle>MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease.</ArticleTitle><Pagination><StartPage>63</StartPage><EndPage>80</EndPage><MedlinePgn>63-80</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00401-020-02156-4</ELocationID><Abstract><AbstractText>Polyglutamine (polyQ) tract expansion leads to proteotoxic misfolding and drives a family of nine diseases. We study spinal and bulbar muscular atrophy (SBMA), a progressive degenerative disorder of the neuromuscular system caused by the polyQ androgen receptor (AR). Using a knock-in mouse model of SBMA, AR113Q mice, we show that E3 ubiquitin ligases which are a hallmark of the canonical muscle atrophy machinery are not induced in AR113Q muscle. Similarly, we find no evidence to suggest dysfunction of signaling pathways that trigger muscle hypertrophy or impairment of the muscle stem cell niche. Instead, we find that skeletal muscle atrophy is characterized by diminished function of the transcriptional regulator Myocyte Enhancer Factor 2 (MEF2), a regulator of myofiber homeostasis. Decreased expression of MEF2 target genes is age- and glutamine tract length-dependent, occurs due to polyQ AR proteotoxicity, and is associated with sequestration of MEF2 into intranuclear inclusions in muscle. Skeletal muscle from R6/2 mice, a model of Huntington disease which develops progressive atrophy, also sequesters MEF2 into inclusions and displays age-dependent loss of MEF2 target genes. Similarly, SBMA patient muscle shows loss of MEF2 target gene expression, and restoring MEF2 activity in AR113Q muscle rescues fiber size and MEF2-regulated gene expression. This work establishes MEF2 impairment as a novel mechanism of skeletal muscle atrophy downstream of toxic polyglutamine proteins and as a therapeutic target for muscle atrophy in these disorders.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nath</LastName><ForeName>Samir R</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0001-6336-7991</Identifier><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Medical Scientist Training Program, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Michigan Medical School, 3510 MSRB1, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Matthew L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Zhigang</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchioretti</LastName><ForeName>Caterina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), 35129, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Myology Center (Cir-Myo), University of Padova, 35129, Paduva, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), 35100, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Samuel T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Huntington's Disease Centre, Department of Neurodegenerative Disease and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Danby</LastName><ForeName>Emily C E</ForeName><Initials>ECE</Initials><AffiliationInfo><Affiliation>Huntington's Disease Centre, Department of Neurodegenerative Disease and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Van Pelt</LastName><ForeName>Kate M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Cellular and Molecular Biology Graduate Program, University of Michigan Medical School, 3510 MSRB1, 1150 W. Medical Center Dr., Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sorar&#xf9;</LastName><ForeName>Gianni</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), 35129, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Myology Center (Cir-Myo), University of Padova, 35129, Paduva, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), 35100, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robins</LastName><ForeName>Diane M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University of Michigan Medical School, Ann Arbor, MI, 48109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bates</LastName><ForeName>Gillian P</ForeName><Initials>GP</Initials><AffiliationInfo><Affiliation>Huntington's Disease Centre, Department of Neurodegenerative Disease and UK Dementia Research Institute at UCL, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pennuto</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Biomedical Sciences (DBS), University of Padova, 35131, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Veneto Institute of Molecular Medicine (VIMM), 35129, Padua, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Myology Center (Cir-Myo), University of Padova, 35129, Paduva, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Padova Neuroscience Center (PNC), 35100, Padua, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lieberman</LastName><ForeName>Andrew P</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Department of Pathology, University of Michigan Medical School, Ann Arbor, MI, 48109, USA. liebermn@umich.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS055746</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007315</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 GM007863</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>04</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Acta Neuropathol</MedlineTA><NlmUniqueID>0412041</NlmUniqueID><ISSNLinking>0001-6322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064326">MEF2 Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010455">Peptides</NameOfSubstance></Chemical><Chemical><RegistryNumber>26700-71-0</RegistryNumber><NameOfSubstance UI="C097188">polyglutamine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055534" MajorTopicYN="N">Bulbo-Spinal Atrophy, X-Linked</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006816" MajorTopicYN="N">Huntington Disease</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064326" MajorTopicYN="N">MEF2 Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009133" MajorTopicYN="N">Muscular Atrophy</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010455" MajorTopicYN="N">Peptides</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors have declared that no conflict of interest exists.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>1</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32306066</ArticleId><ArticleId IdType="pmc">PMC7166004</ArticleId><ArticleId IdType="doi">10.1007/s00401-020-02156-4</ArticleId><ArticleId IdType="pii">10.1007/s00401-020-02156-4</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Albertelli MA, Scheller A, Brogley M, Robins DM. Replacing the mouse androgen receptor with human alleles demonstrates glutamine tract length-dependent effects on physiology and tumorigenesis in mice. Mol Endocrinol. 2006;20:1248&#x2013;1260. doi: 10.1210/me.2006-0021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/me.2006-0021</ArticleId><ArticleId IdType="pubmed">16601069</ArticleId></ArticleIdList></Reference><Reference><Citation>Amato AA, Prior TW, Barohn RJ, Snyder P, Papp A, Mendell JR. Kennedy's disease: a clinicopathologic correlation with mutations in the androgen receptor gene. Neurology. 1993;43:791&#x2013;794. doi: 10.1212/wnl.43.4.791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.43.4.791</ArticleId><ArticleId IdType="pubmed">8469342</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson CM, Hu J, Barnes RM, Heidt AB, Cornelissen I, Black BL. Myocyte enhancer factor 2C function in skeletal muscle is required for normal growth and glucose metabolism in mice. Skelet Muscle. 2015;5:7. doi: 10.1186/s13395-015-0031-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-015-0031-0</ArticleId><ArticleId IdType="pmc">PMC4364460</ArticleId><ArticleId IdType="pubmed">25789156</ArticleId></ArticleIdList></Reference><Reference><Citation>Andzelm MM, Vanness D, Greenberg ME, Linden DJ. A late phase of long-term synaptic depression in cerebellar purkinje cells requires activation of MEF2. Cell Rep. 2019;26(1089&#x2013;1097):e1083. doi: 10.1016/j.celrep.2019.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.01.004</ArticleId><ArticleId IdType="pmc">PMC6433166</ArticleId><ArticleId IdType="pubmed">30699340</ArticleId></ArticleIdList></Reference><Reference><Citation>Atsuta N, Watanabe H, Ito M, Banno H, Suzuki K, Katsuno M, et al. Natural history of spinal and bulbar muscular atrophy (SBMA): a study of 223 Japanese patients. Brain. 2006;129:1446&#x2013;1455. doi: 10.1093/brain/awl096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awl096</ArticleId><ArticleId IdType="pubmed">16621916</ArticleId></ArticleIdList></Reference><Reference><Citation>Attia M, Maurer M, Robinet M, Le Grand F, Fadel E, Le Panse R, et al. Muscle satellite cells are functionally impaired in myasthenia gravis: consequences on muscle regeneration. Acta Neuropathol. 2017 doi: 10.1007/s00401-017-1754-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1754-2</ArticleId><ArticleId IdType="pubmed">28756524</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodine SC, Baehr LM. Skeletal muscle atrophy and the E3 ubiquitin ligases MuRF1 and MAFbx/atrogin-1. Am J Physiol Endocrinol Metab. 2014;307:E469&#x2013;484. doi: 10.1152/ajpendo.00204.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00204.2014</ArticleId><ArticleId IdType="pmc">PMC4166716</ArticleId><ArticleId IdType="pubmed">25096180</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L, Clarke BA, et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science. 2001;294:1704&#x2013;1708. doi: 10.1126/science.1065874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1065874</ArticleId><ArticleId IdType="pubmed">11679633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3:1014&#x2013;1019. doi: 10.1038/ncb1101-1014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1101-1014</ArticleId><ArticleId IdType="pubmed">11715023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bondulich MK, Jolinon N, Osborne GF, Smith EJ, Rattray I, Neueder A, et al. Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice. Sci Rep. 2017;7:14275. doi: 10.1038/s41598-017-14290-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14290-3</ArticleId><ArticleId IdType="pmc">PMC5660167</ArticleId><ArticleId IdType="pubmed">29079832</ArticleId></ArticleIdList></Reference><Reference><Citation>Brugarolas J, Lei K, Hurley RL, Manning BD, Reiling JH, Hafen E, et al. Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 2004;18:2893&#x2013;2904. doi: 10.1101/gad.1256804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.1256804</ArticleId><ArticleId IdType="pmc">PMC534650</ArticleId><ArticleId IdType="pubmed">15545625</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha JH, Kosinski CM, Kerner JA, Alsdorf SA, Mangiarini L, Davies SW, et al. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. Proc Natl Acad Sci USA. 1998;95:6480&#x2013;6485. doi: 10.1073/pnas.95.11.6480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.95.11.6480</ArticleId><ArticleId IdType="pmc">PMC27817</ArticleId><ArticleId IdType="pubmed">9600992</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, Lieberman AP. Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy. CNS Neurol Disord Drug Targets. 2013;12:1146&#x2013;1156.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4003563</ArticleId><ArticleId IdType="pubmed">24040817</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua JP, Reddy SL, Yu Z, Giorgetti E, Montie HL, Mukherjee S, et al. Disrupting SUMOylation enhances transcriptional function and ameliorates polyglutamine androgen receptor-mediated disease. J Clin Invest. 2015;125:831&#x2013;845. doi: 10.1172/JCI73214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI73214</ArticleId><ArticleId IdType="pmc">PMC4319414</ArticleId><ArticleId IdType="pubmed">25607844</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Nathan JA, Goldberg AL. Muscle wasting in disease: molecular mechanisms and promising therapies. Nat Rev Drug Discov. 2015;14:58&#x2013;74. doi: 10.1038/nrd4467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4467</ArticleId><ArticleId IdType="pubmed">25549588</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen TJ, Barrientos T, Hartman ZC, Garvey SM, Cox GA, Yao TP. The deacetylase HDAC4 controls myocyte enhancing factor-2-dependent structural gene expression in response to neural activity. FASEB J. 2009;23:99&#x2013;106. doi: 10.1096/fj.08-115931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.08-115931</ArticleId><ArticleId IdType="pmc">PMC2626618</ArticleId><ArticleId IdType="pubmed">18780762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, Ly L, et al. Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy. Neuron. 2014;82:295&#x2013;307. doi: 10.1016/j.neuron.2014.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.03.001</ArticleId><ArticleId IdType="pmc">PMC4096235</ArticleId><ArticleId IdType="pubmed">24742458</ArticleId></ArticleIdList></Reference><Reference><Citation>Crist CG, Montarras D, Buckingham M. Muscle satellite cells are primed for myogenesis but maintain quiescence with sequestration of Myf5 mRNA targeted by microRNA-31 in mRNP granules. Cell Stem Cell. 2012;11:118&#x2013;126. doi: 10.1016/j.stem.2012.03.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2012.03.011</ArticleId><ArticleId IdType="pubmed">22770245</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadson K, Turdi S, Hashemi S, Zhao J, Polidovitch N, Beca S, et al. Adiponectin is required for cardiac MEF2 activation during pressure overload induced hypertrophy. J Mol Cell Cardiol. 2015;86:102&#x2013;109. doi: 10.1016/j.yjmcc.2015.06.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yjmcc.2015.06.020</ArticleId><ArticleId IdType="pubmed">26196305</ArticleId></ArticleIdList></Reference><Reference><Citation>De Simone A, Kitchen C, Kwan AH, Sunde M, Dobson CM, Frenkel D. Intrinsic disorder modulates protein self-assembly and aggregation. Proc Natl Acad Sci USA. 2012;109:6951&#x2013;6956. doi: 10.1073/pnas.1118048109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1118048109</ArticleId><ArticleId IdType="pmc">PMC3344965</ArticleId><ArticleId IdType="pubmed">22509003</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunah AW, Jeong H, Griffin A, Kim YM, Standaert DG, Hersch SM, et al. Sp1 and TAFII130 transcriptional activity disrupted in early Huntington's disease. Science. 2002;296:2238&#x2013;2243. doi: 10.1126/science.1072613.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1072613</ArticleId><ArticleId IdType="pubmed">11988536</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert SM, Dyle MC, Kunkel SD, Bullard SA, Bongers KS, Fox DK, et al. Stress-induced skeletal muscle Gadd45a expression reprograms myonuclei and causes muscle atrophy. J Biol Chem. 2012;287:27290&#x2013;27301. doi: 10.1074/jbc.M112.374777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.374777</ArticleId><ArticleId IdType="pmc">PMC3431665</ArticleId><ArticleId IdType="pubmed">22692209</ArticleId></ArticleIdList></Reference><Reference><Citation>Eftekharzadeh B, Banduseela VC, Chiesa G, Martinez-Cristobal P, Rauch JN, Nath SR, et al. Hsp70 and Hsp40 inhibit an inter-domain interaction necessary for transcriptional activity in the androgen receptor. Nat Commun. 2019;10:3562. doi: 10.1038/s41467-019-11594-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11594-y</ArticleId><ArticleId IdType="pmc">PMC6687723</ArticleId><ArticleId IdType="pubmed">31395886</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell SW, Cowan CW, Kim TK, Greer PL, Lin Y, Paradis S, et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science. 2006;311:1008&#x2013;1012. doi: 10.1126/science.1122511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1122511</ArticleId><ArticleId IdType="pubmed">16484497</ArticleId></ArticleIdList></Reference><Reference><Citation>Flavell SW, Kim TK, Gray JM, Harmin DA, Hemberg M, Hong EJ, et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron. 2008;60:1022&#x2013;1038. doi: 10.1016/j.neuron.2008.11.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2008.11.029</ArticleId><ArticleId IdType="pmc">PMC2630178</ArticleId><ArticleId IdType="pubmed">19109909</ArticleId></ArticleIdList></Reference><Reference><Citation>Giorgetti E, Yu Z, Chua JP, Shimamura R, Zhao L, Zhu F, et al. Rescue of metabolic alterations in AR113Q skeletal muscle by peripheral androgen receptor gene silencing. Cell Rep. 2016;17:125&#x2013;136. doi: 10.1016/j.celrep.2016.08.084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2016.08.084</ArticleId><ArticleId IdType="pmc">PMC5076565</ArticleId><ArticleId IdType="pubmed">27681426</ArticleId></ArticleIdList></Reference><Reference><Citation>Gunther S, Kim J, Kostin S, Lepper C, Fan CM, Braun T. Myf5-positive satellite cells contribute to Pax7-dependent long-term maintenance of adult muscle stem cells. Cell Stem Cell. 2013;13:590&#x2013;601. doi: 10.1016/j.stem.2013.07.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2013.07.016</ArticleId><ArticleId IdType="pmc">PMC4082715</ArticleId><ArticleId IdType="pubmed">23933088</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardy D, Besnard A, Latil M, Jouvion G, Briand D, Thepenier C, et al. Comparative study of injury models for studying muscle regeneration in mice. PLoS ONE. 2016;11:e0147198. doi: 10.1371/journal.pone.0147198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0147198</ArticleId><ArticleId IdType="pmc">PMC4726569</ArticleId><ArticleId IdType="pubmed">26807982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu CC, Buehler MJ, Tarakanova A. The order-disorder continuum: linking predictions of protein structure and disorder through molecular simulation. Sci Rep. 2020;10:2068. doi: 10.1038/s41598-020-58868-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-58868-w</ArticleId><ArticleId IdType="pmc">PMC7005769</ArticleId><ArticleId IdType="pubmed">32034199</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozhemyakina E, Cohen T, Yao TP, Lassar AB. Parathyroid hormone-related peptide represses chondrocyte hypertrophy through a protein phosphatase 2A/histone deacetylase 4/MEF2 pathway. Mol Cell Biol. 2009;29:5751&#x2013;5762. doi: 10.1128/MCB.00415-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.00415-09</ArticleId><ArticleId IdType="pmc">PMC2772746</ArticleId><ArticleId IdType="pubmed">19704004</ArticleId></ArticleIdList></Reference><Reference><Citation>Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB J. 2004;18:39&#x2013;51. doi: 10.1096/fj.03-0610com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.03-0610com</ArticleId><ArticleId IdType="pubmed">14718385</ArticleId></ArticleIdList></Reference><Reference><Citation>Leger B, Vergani L, Soraru G, Hespel P, Derave W, Gobelet C, et al. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583&#x2013;585. doi: 10.1096/fj.05-5249fje.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.05-5249fje</ArticleId><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Li C, Vu K, Hazelgrove K, Kuemmerle JF. Increased IGF-IEc expression and mechano-growth factor production in intestinal muscle of fibrostenotic Crohn's disease and smooth muscle hypertrophy. Am J Physiol Gastrointest Liver Physiol. 2015;309:G888&#x2013;899. doi: 10.1152/ajpgi.00414.2014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpgi.00414.2014</ArticleId><ArticleId IdType="pmc">PMC4669353</ArticleId><ArticleId IdType="pubmed">26428636</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Sobue G, Doyu M, Mukai E, Hashizume Y, Mitsuma T. Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression. Muscle Nerve. 1995;18:301&#x2013;308. doi: 10.1002/mus.880180306.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880180306</ArticleId><ArticleId IdType="pubmed">7870107</ArticleId></ArticleIdList></Reference><Reference><Citation>Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, et al. Interaction of Huntington disease protein with transcriptional activator Sp1. Mol Cell Biol. 2002;22:1277&#x2013;1287. doi: 10.1128/mcb.22.5.1277-1287.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.22.5.1277-1287.2002</ArticleId><ArticleId IdType="pmc">PMC134707</ArticleId><ArticleId IdType="pubmed">11839795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Harmison G, Strand AD, Olson JM, Fischbeck KH. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum Mol Genet. 2002;11:1967&#x2013;1976. doi: 10.1093/hmg/11.17.1967.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/11.17.1967</ArticleId><ArticleId IdType="pubmed">12165558</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Shakkottai VG, Albin RL. Polyglutamine repeats in neurodegenerative diseases. Annu Rev Pathol. 2019;14:1&#x2013;27. doi: 10.1146/annurev-pathmechdis-012418-012857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pathmechdis-012418-012857</ArticleId><ArticleId IdType="pmc">PMC6387631</ArticleId><ArticleId IdType="pubmed">30089230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lieberman AP, Yu Z, Murray S, Peralta R, Low A, Guo S, et al. Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy. Cell Rep. 2014;7:774&#x2013;784. doi: 10.1016/j.celrep.2014.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.02.008</ArticleId><ArticleId IdType="pmc">PMC4356525</ArticleId><ArticleId IdType="pubmed">24746732</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu N, Nelson BR, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, et al. Requirement of MEF2A, C, and D for skeletal muscle regeneration. Proc Natl Acad Sci USA. 2014;111:4109&#x2013;4114. doi: 10.1073/pnas.1401732111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1401732111</ArticleId><ArticleId IdType="pmc">PMC3964114</ArticleId><ArticleId IdType="pubmed">24591619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma K, Chan JK, Zhu G, Wu Z. Myocyte enhancer factor 2 acetylation by p300 enhances its DNA binding activity, transcriptional activity, and myogenic differentiation. Mol Cell Biol. 2005;25:3575&#x2013;3582. doi: 10.1128/MCB.25.9.3575-3582.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.9.3575-3582.2005</ArticleId><ArticleId IdType="pmc">PMC1084296</ArticleId><ArticleId IdType="pubmed">15831463</ArticleId></ArticleIdList></Reference><Reference><Citation>Majidi SP, Reddy NC, Moore MJ, Chen H, Yamada T, Andzelm MM, et al. Chromatin environment and cellular context specify compensatory activity of paralogous MEF2 transcription factors. Cell Rep. 2019;29(2001&#x2013;2015):e2005. doi: 10.1016/j.celrep.2019.10.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.10.033</ArticleId><ArticleId IdType="pmc">PMC6874310</ArticleId><ArticleId IdType="pubmed">31722213</ArticleId></ArticleIdList></Reference><Reference><Citation>Malena A, Pennuto M, Tezze C, Querin G, D'Ascenzo C, Silani V, et al. Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy. Acta Neuropathol. 2013;126:109&#x2013;121. doi: 10.1007/s00401-013-1122-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1122-9</ArticleId><ArticleId IdType="pubmed">23644820</ArticleId></ArticleIdList></Reference><Reference><Citation>Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell. 1996;87:493&#x2013;506. doi: 10.1016/s0092-8674(00)81369-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(00)81369-0</ArticleId><ArticleId IdType="pubmed">8898202</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao Z, Bonni A, Xia F, Nadal-Vicens M, Greenberg ME. Neuronal activity-dependent cell survival mediated by transcription factor MEF2. Science. 1999;286:785&#x2013;790. doi: 10.1126/science.286.5440.785.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.286.5440.785</ArticleId><ArticleId IdType="pubmed">10531066</ArticleId></ArticleIdList></Reference><Reference><Citation>McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature. 1997;387:83&#x2013;90. doi: 10.1038/387083a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/387083a0</ArticleId><ArticleId IdType="pubmed">9139826</ArticleId></ArticleIdList></Reference><Reference><Citation>Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, Rouleau G, et al. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat Genet. 1993;5:184&#x2013;188. doi: 10.1038/ng1093-184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1093-184</ArticleId><ArticleId IdType="pubmed">8252045</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielcarek M, Toczek M, Smeets CJ, Franklin SA, Bondulich MK, Jolinon N, et al. HDAC4-myogenin axis as an important marker of HD-related skeletal muscle atrophy. PLoS Genet. 2015;11:e1005021. doi: 10.1371/journal.pgen.1005021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1005021</ArticleId><ArticleId IdType="pmc">PMC4352047</ArticleId><ArticleId IdType="pubmed">25748626</ArticleId></ArticleIdList></Reference><Reference><Citation>Molkentin JD, Li L, Olson EN. Phosphorylation of the MADS-Box transcription factor MEF2C enhances its DNA binding activity. J Biol Chem. 1996;271:17199&#x2013;17204. doi: 10.1074/jbc.271.29.17199.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.271.29.17199</ArticleId><ArticleId IdType="pubmed">8663403</ArticleId></ArticleIdList></Reference><Reference><Citation>Monks DA, Johansen JA, Mo K, Rao P, Eagleson B, Yu Z, et al. Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease. Proc Natl Acad Sci USA. 2007;104:18259&#x2013;18264. doi: 10.1073/pnas.0705501104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0705501104</ArticleId><ArticleId IdType="pmc">PMC2084330</ArticleId><ArticleId IdType="pubmed">17984063</ArticleId></ArticleIdList></Reference><Reference><Citation>Montie HL, Cho MS, Holder L, Liu Y, Tsvetkov AS, Finkbeiner S, et al. Cytoplasmic retention of polyglutamine-expanded androgen receptor ameliorates disease via autophagy in a mouse model of spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:1937&#x2013;1950. doi: 10.1093/hmg/ddp115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp115</ArticleId><ArticleId IdType="pmc">PMC2678926</ArticleId><ArticleId IdType="pubmed">19279159</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti I, Ciciliot S, Dyar KA, Abraham R, Murgia M, Agatea L, et al. MRF4 negatively regulates adult skeletal muscle growth by repressing MEF2 activity. Nat Commun. 2016;7:12397. doi: 10.1038/ncomms12397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms12397</ArticleId><ArticleId IdType="pmc">PMC4976255</ArticleId><ArticleId IdType="pubmed">27484840</ArticleId></ArticleIdList></Reference><Reference><Citation>Narain Y, Wyttenbach A, Rankin J, Furlong RA, Rubinsztein DC. A molecular investigation of true dominance in Huntington's disease. J Med Genet. 1999;36:739&#x2013;746. doi: 10.1136/jmg.36.10.739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jmg.36.10.739</ArticleId><ArticleId IdType="pmc">PMC1734229</ArticleId><ArticleId IdType="pubmed">10528852</ArticleId></ArticleIdList></Reference><Reference><Citation>Nath SR, Yu Z, Gipson TA, Marsh GB, Yoshidome E, Robins DM, et al. Androgen receptor polyglutamine expansion drives age-dependent quality control defects and muscle dysfunction. J Clin Invest. 2018;128:3630&#x2013;3641. doi: 10.1172/JCI99042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99042</ArticleId><ArticleId IdType="pmc">PMC6063498</ArticleId><ArticleId IdType="pubmed">29809168</ArticleId></ArticleIdList></Reference><Reference><Citation>Nedelsky NB, Pennuto M, Smith RB, Palazzolo I, Moore J, Nie Z, et al. Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy. Neuron. 2010;67:936&#x2013;952. doi: 10.1016/j.neuron.2010.08.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.08.034</ArticleId><ArticleId IdType="pmc">PMC3514079</ArticleId><ArticleId IdType="pubmed">20869592</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohanna M, Sobering AK, Lapointe T, Lorenzo L, Praud C, Petroulakis E, et al. Atrophy of S6K1(&#x2212;/&#x2212;) skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control. Nat Cell Biol. 2005;7:286&#x2013;294. doi: 10.1038/ncb1231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb1231</ArticleId><ArticleId IdType="pubmed">15723049</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney RK, Aminoff MJ, So YT. Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy. Neurology. 1991;41:823&#x2013;828. doi: 10.1212/wnl.41.6.823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.41.6.823</ArticleId><ArticleId IdType="pubmed">2046924</ArticleId></ArticleIdList></Reference><Reference><Citation>Palazzolo I, Stack C, Kong L, Musaro A, Adachi H, Katsuno M, et al. Overexpression of IGF-1 in muscle attenuates disease in a mouse model of spinal and bulbar muscular atrophy. Neuron. 2009;63:316&#x2013;328. doi: 10.1016/j.neuron.2009.07.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2009.07.019</ArticleId><ArticleId IdType="pmc">PMC2735765</ArticleId><ArticleId IdType="pubmed">19679072</ArticleId></ArticleIdList></Reference><Reference><Citation>Park SY, Yun Y, Lim JS, Kim MJ, Kim SY, Kim JE, et al. Stabilin-2 modulates the efficiency of myoblast fusion during myogenic differentiation and muscle regeneration. Nat Commun. 2016;7:10871. doi: 10.1038/ncomms10871.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10871</ArticleId><ArticleId IdType="pmc">PMC4793076</ArticleId><ArticleId IdType="pubmed">26972991</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson TR, Laplante M, Thoreen CC, Sancak Y, Kang SA, Kuehl WM, et al. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival. Cell. 2009;137:873&#x2013;886. doi: 10.1016/j.cell.2009.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2009.03.046</ArticleId><ArticleId IdType="pmc">PMC2758791</ArticleId><ArticleId IdType="pubmed">19446321</ArticleId></ArticleIdList></Reference><Reference><Citation>Polo A, Teatini F, D'Anna S, Manganotti P, Salviati A, Dallapiccola B, et al. Sensory involvement in X-linked spino-bulbar muscular atrophy (Kennedy's syndrome): an electrophysiological study. J Neurol. 1996;243:388&#x2013;392. doi: 10.1007/bf00868997.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00868997</ArticleId><ArticleId IdType="pubmed">8741078</ArticleId></ArticleIdList></Reference><Reference><Citation>Potthoff MJ, Arnold MA, McAnally J, Richardson JA, Bassel-Duby R, Olson EN. Regulation of skeletal muscle sarcomere integrity and postnatal muscle function by Mef2c. Mol Cell Biol. 2007;27:8143&#x2013;8151. doi: 10.1128/MCB.01187-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01187-07</ArticleId><ArticleId IdType="pmc">PMC2169182</ArticleId><ArticleId IdType="pubmed">17875930</ArticleId></ArticleIdList></Reference><Reference><Citation>Pratt WB, Gestwicki JE, Osawa Y, Lieberman AP. Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases. Annu Rev Pharmacol Toxicol. 2015;55:353&#x2013;371. doi: 10.1146/annurev-pharmtox-010814-124332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-pharmtox-010814-124332</ArticleId><ArticleId IdType="pmc">PMC4372135</ArticleId><ArticleId IdType="pubmed">25292434</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramzan F, McPhail M, Rao P, Mo K, Halievski K, Swift-Gallant A, et al. Distinct etiological roles for myocytes and motor neurons in a mouse model of kennedy's disease/spinobulbar muscular atrophy. J Neurosci. 2015;35:6444&#x2013;6451. doi: 10.1523/JNEUROSCI.3599-14.2015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3599-14.2015</ArticleId><ArticleId IdType="pmc">PMC6605215</ArticleId><ArticleId IdType="pubmed">25904795</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranganathan S, Harmison GG, Meyertholen K, Pennuto M, Burnett BG, Fischbeck KH. Mitochondrial abnormalities in spinal and bulbar muscular atrophy. Hum Mol Genet. 2009;18:27&#x2013;42. doi: 10.1093/hmg/ddn310.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn310</ArticleId><ArticleId IdType="pmc">PMC2644643</ArticleId><ArticleId IdType="pubmed">18824496</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhodes LE, Freeman BK, Auh S, Kokkinis AD, La Pean A, Chen C, et al. Clinical features of spinal and bulbar muscular atrophy. Brain. 2009;132:3242&#x2013;3251. doi: 10.1093/brain/awp258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp258</ArticleId><ArticleId IdType="pmc">PMC2792370</ArticleId><ArticleId IdType="pubmed">19846582</ArticleId></ArticleIdList></Reference><Reference><Citation>Rocchi A, Milioto C, Parodi S, Armirotti A, Borgia D, Pellegrini M, et al. Glycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat diet. Acta Neuropathol. 2016;132:127&#x2013;144. doi: 10.1007/s00401-016-1550-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-016-1550-4</ArticleId><ArticleId IdType="pmc">PMC4911374</ArticleId><ArticleId IdType="pubmed">26971100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacheck JM, Hyatt JP, Raffaello A, Jagoe RT, Roy RR, Edgerton VR, et al. Rapid disuse and denervation atrophy involve transcriptional changes similar to those of muscle wasting during systemic diseases. FASEB J. 2007;21:140&#x2013;155. doi: 10.1096/fj.06-6604com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.06-6604com</ArticleId><ArticleId IdType="pubmed">17116744</ArticleId></ArticleIdList></Reference><Reference><Citation>Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E, et al. BMP signaling controls muscle mass. Nat Genet. 2013;45:1309&#x2013;1318. doi: 10.1038/ng.2772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.2772</ArticleId><ArticleId IdType="pubmed">24076600</ArticleId></ArticleIdList></Reference><Reference><Citation>Sathasivam K, Lane A, Legleiter J, Warley A, Woodman B, Finkbeiner S, et al. Identical oligomeric and fibrillar structures captured from the brains of R6/2 and knock-in mouse models of Huntington's disease. Hum Mol Genet. 2010;19:65&#x2013;78. doi: 10.1093/hmg/ddp467.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddp467</ArticleId><ArticleId IdType="pmc">PMC2792149</ArticleId><ArticleId IdType="pubmed">19825844</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaramuzzino C, Casci I, Parodi S, Lievens PMJ, Polanco MJ, Milioto C, et al. Protein arginine methyltransferase 6 enhances polyglutamine-expanded androgen receptor function and toxicity in spinal and bulbar muscular atrophy. Neuron. 2015;85:88&#x2013;100. doi: 10.1016/j.neuron.2014.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.12.031</ArticleId><ArticleId IdType="pmc">PMC4305189</ArticleId><ArticleId IdType="pubmed">25569348</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S, Dyar KA, Ciciliot S, Blaauw B, Sandri M. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013;280:4294&#x2013;4314. doi: 10.1111/febs.12253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/febs.12253</ArticleId><ArticleId IdType="pubmed">23517348</ArticleId></ArticleIdList></Reference><Reference><Citation>Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, Takahashi A. X-linked recessive bulbospinal neuronapathy. A clinicopathological study. Brain. 1989;112(Pt 1):209&#x2013;232. doi: 10.1093/brain/112.1.209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/112.1.209</ArticleId><ArticleId IdType="pubmed">2917278</ArticleId></ArticleIdList></Reference><Reference><Citation>Sofer A, Lei K, Johannessen CM, Ellisen LW. Regulation of mTOR and cell growth in response to energy stress by REDD1. Mol Cell Biol. 2005;25:5834&#x2013;5845. doi: 10.1128/MCB.25.14.5834-5845.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.25.14.5834-5845.2005</ArticleId><ArticleId IdType="pmc">PMC1168803</ArticleId><ArticleId IdType="pubmed">15988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Soraru G, D'Ascenzo C, Polo A, Palmieri A, Baggio L, Vergani L, et al. Spinal and bulbar muscular atrophy: skeletal muscle pathology in male patients and heterozygous females. J Neurol Sci. 2008;264:100&#x2013;105. doi: 10.1016/j.jns.2007.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2007.08.012</ArticleId><ArticleId IdType="pubmed">17854832</ArticleId></ArticleIdList></Reference><Reference><Citation>Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, et al. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci USA. 2000;97:6763&#x2013;6768. doi: 10.1073/pnas.100110097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.100110097</ArticleId><ArticleId IdType="pmc">PMC18731</ArticleId><ArticleId IdType="pubmed">10823891</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky VN. Intrinsically disordered proteins and their (disordered) proteomes in neurodegenerative disorders. Front Aging Neurosci. 2015;7:18. doi: 10.3389/fnagi.2015.00018.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00018</ArticleId><ArticleId IdType="pmc">PMC4345837</ArticleId><ArticleId IdType="pubmed">25784874</ArticleId></ArticleIdList></Reference><Reference><Citation>Walcott JL, Merry DE. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J Biol Chem. 2002;277:50855&#x2013;50859. doi: 10.1074/jbc.M209466200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M209466200</ArticleId><ArticleId IdType="pubmed">12388541</ArticleId></ArticleIdList></Reference><Reference><Citation>Wales S, Hashemi S, Blais A, McDermott JC. Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling. Nucleic Acids Res. 2014;42:11349&#x2013;11362. doi: 10.1093/nar/gku813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku813</ArticleId><ArticleId IdType="pmc">PMC4191398</ArticleId><ArticleId IdType="pubmed">25217591</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang AM, Miyata Y, Klinedinst S, Peng H-MM, Chua JP, Komiyama T, et al. Activation of Hsp70 reduces neurotoxicity by promoting polyglutamine protein degradation. Nat Chem Biol. 2013;9:112&#x2013;118. doi: 10.1038/nchembio.1140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1140</ArticleId><ArticleId IdType="pmc">PMC3552084</ArticleId><ArticleId IdType="pubmed">23222885</ArticleId></ArticleIdList></Reference><Reference><Citation>Woronicz JD, Lina A, Calnan BJ, Szychowski S, Cheng L, Winoto A. Regulation of the Nur77 orphan steroid receptor in activation-induced apoptosis. Mol Cell Biol. 1995;15:6364&#x2013;6376. doi: 10.1128/mcb.15.11.6364.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.15.11.6364</ArticleId><ArticleId IdType="pmc">PMC230888</ArticleId><ArticleId IdType="pubmed">7565789</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto H, Williams EG, Mouchiroud L, Canto C, Fan W, Downes M, et al. NCoR1 is a conserved physiological modulator of muscle mass and oxidative function. Cell. 2011;147:827&#x2013;839. doi: 10.1016/j.cell.2011.10.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2011.10.017</ArticleId><ArticleId IdType="pmc">PMC3225739</ArticleId><ArticleId IdType="pubmed">22078881</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu YT, Breitbart RE, Smoot LB, Lee Y, Mahdavi V, Nadal-Ginard B. Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev. 1992;6:1783&#x2013;1798. doi: 10.1101/gad.6.9.1783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.6.9.1783</ArticleId><ArticleId IdType="pubmed">1516833</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Gruis K, Jordan C, Robins DM, et al. Androgen-dependent pathology demonstrates myopathic contribution to the Kennedy disease phenotype in a mouse knock-in model. J Clin Investig. 2006;116:2663&#x2013;2672. doi: 10.1172/JCI28773.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI28773</ArticleId><ArticleId IdType="pmc">PMC1564432</ArticleId><ArticleId IdType="pubmed">16981011</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Z, Dadgar N, Albertelli M, Scheller A, Albin RL, Robins DM, et al. Abnormalities of germ cell maturation and sertoli cell cytoskeleton in androgen receptor 113 CAG knock-in mice reveal toxic effects of the mutant protein. Am J Pathol. 2006;168:195&#x2013;204. doi: 10.2353/ajpath.2006.050619.</Citation><ArticleIdList><ArticleId IdType="doi">10.2353/ajpath.2006.050619</ArticleId><ArticleId IdType="pmc">PMC1592669</ArticleId><ArticleId IdType="pubmed">16400023</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, New L, Kravchenko VV, Kato Y, Gram H, di Padova F, et al. Regulation of the MEF2 family of transcription factors by p38. Mol Cell Biol. 1999;19:21&#x2013;30. doi: 10.1128/mcb.19.1.21.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.19.1.21</ArticleId><ArticleId IdType="pmc">PMC83862</ArticleId><ArticleId IdType="pubmed">9858528</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>